[1]殷　波,赵寅滢.亚胺培南西司他丁钠治疗重症肺炎疗效观察[J].新乡医学院学报,2017,34(12):1128-1130.[doi:10.7683/xxyxyxb.2017.12.022]
　YIN Bo,ZHAO Yin-ying.Effect of imipenem and cilastatin sodium in the treatment of severe pneumonia[J].Journal of Xinxiang Medical University,2017,34(12):1128-1130.[doi:10.7683/xxyxyxb.2017.12.022]
点击复制

亚胺培南西司他丁钠治疗重症肺炎疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年12
页码:
1128-1130
栏目:
临床研究
出版日期:
2017-12-05

文章信息/Info

Title:
Effect of imipenem and cilastatin sodium in the treatment of severe pneumonia
作者:
殷　波; 赵寅滢
（南京医科大学附属无锡市人民医院呼吸科，江苏　无锡　214002）
Author(s):
YIN Bo; ZHAO Yin-ying
（Department of Pneumology，Wuxi People′s Hospital Affiliated to Nanjing Medical University，Wuxi 214002，Jiangsu Province，China）
关键词:
重症肺炎; 亚胺培南西司他丁钠; 降钙素原; C反应蛋白; 咳嗽评分
Keywords:
severe pneumonia; imipenem and cilastatin sodium; procalcitonin; C-reactive protein; cough score
分类号:
R563.1
DOI:
10.7683/xxyxyxb.2017.12.022
文献标志码:
A
摘要:
目的　探讨亚胺培南西司他丁钠治疗重症肺炎的临床效果。方法　选取2013年5月至2016年8月无锡市人民医院收治的重症肺炎患者60例，按治疗方法分为观察组和对照组，每组30例。对照组患者给予注射用头孢哌酮舒巴坦治疗，观察组患者给予亚胺培南西司他丁钠治疗，疗程7～10 d。分别于治疗前后测定2组患者血清降钙素原（PCT）和C反应蛋白（CRP）水平，并进行咳嗽评分；治疗结束后评定2组患者临床疗效，并记录患者不良反应。结果　治疗前2组患者血清PCT、CRP水平比较差异均无统计学意义（P>0.05），2组患者治疗后血清PCT、CRP水平显著低于治疗前（P<0.05），治疗后观察组患者血清PCT、CRP水平显著低于对照组（P<0.05）。治疗前2组患者咳嗽评分比较差异无统计学意义（P>0.05），2组患者治疗后咳嗽评分显著低于治疗前（P<0.05），治疗后观察组患者咳嗽评分显著低于对照组（P<0.05）。观察组和对照组患者治疗总有效率分别为93.33%（14/15）、60.00%（9/15），观察组患者治疗总有效率显著高于对照组（χ2=4.658，P<0.05）。2组患者不良反应发生率均为6.67%，差异无统计学意义（χ2=0.000，P>0.05）。结论　亚胺培南西司他丁钠能够显著减轻重症肺炎患者的炎症反应及临床症状，疗效显著。
Abstract:
Objective　To investigate the clinical effect of imipenem and cilastatin sodium in the treatment of severe pneumonia.Methods　Sixty patients with severe pneumonia were selected from May 2013 to August 2016 in Wuxi People′s Hospital.The patients were divided into observation group and control group according to the treatment method，30 cases in each group.The patients in the control group were treated with cefoperazone and sulbactam injection，and the patients in the observation group were treated with imipenem and cilastatin sodium.The levels of serum procalcitonin （PCT） and C-reactive protein （CRP） were measured，and the cough score was performed in the two groups before and after treatment.The clinical effect was evaluated after treatment，and the adverse reactions of the patients were recorded in the two groups.Results　There were no significant difference in the levels of serum PCT and CRP between the two groups before treatment （P>0.05）.The levels of serum PCT and CRP after treatment were significantly lower than those before treatment in the two groups （P<0.05）.The levels of serum PCT and CRP in the observation group were significantly lower than those in the control group after treatment （P<0.05）.There was no significant difference in cough score between the two groups before treatment （P>0.05）.The cough score after treatment was significantly lower than that before treatment in the two groups （P<0.05）.The cough score in the observation group was significantly lower than that in the control group after treatment （P<0.05）.The total effective rate in the observation group and the control group was 93.33% （14/15） and 60.00% （9/15） respectively，the total effective rate in the observation group was significantly higher than that in the control group （χ2=4.658，P<0.05）.The incidence of adverse reactions in the two groups was 6.67%，there was no significant difference in the incidence of adverse reactions between the two groups（χ2=0.000，P>0.05）.Conclusion　Imipenem and cilastatin sodium can significantly reduce the inflammatory response and clinical symptoms in patients with severe pneumonia，and the curative effect is remarkable.

参考文献/References:

［1］　张志强，马海英，冯宪军，等.重症肺炎合并重度急性呼吸窘迫综合征患者临床特点与预后影响因素分析［J］.中华医院感染学杂志，2016，26（6）：1297-1299.
［2］　张风林，安玉英，刘洪洲.亚胺培南西司他丁治疗老年肺部感染的疗效观察与药动学研究［J］.中国医院用药评价与分析，2017，17（1）：52-54.
［3］　何梦静，周威.亚胺培南西司他丁钠的临床应用及注意事项［J］.中国临床研究，2017，30（8）：1126-1127，1130.
［4］　中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南：2016年版［J］.中华结核和呼吸杂志，2016，39（4）：253-279.
［5］　中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南：2009版［J］.中华结核和呼吸杂志，2009，32（6）：407-413.
［6］　沙正凯，钱江，张祥杰，等.抗感染联合纤维支气管镜吸痰治疗对重症肺炎患者症状缓解及炎性反应的影响［J］.新乡医学院学报，2016，33（12）：1091-1094.
［7］　徐建华，王导新.肺炎重症化机制的研究进展［J］.临床肺科杂志，2012，17（8）：1483-1484.
［8］　蔡少艾，徐米清.降钙素原对老年急性左心衰竭合并社区获得性肺炎患者的临床价值［J］.中华老年医学杂志，2016，35（11）：3485-3487.
［9］　石建邦，吴健卫，徐非洲，等.慢性阻塞性肺疾病急性加重期患者血清降钙素原检测的临床意义［J］.中国老年学杂志，2017，37（5）：1178-1180.
［10］　臧宁，潘海祥，李荣新，等.降钙素原和C反应蛋白联合检测在重症肺炎患儿病情和预后评估中的价值［J］.新乡医学院学报，2015，32（9）：849-851.
［11］　刘强，许琳.乳酸及C反应蛋白联合检测对重症肺炎的诊断价值［J］.中国感染控制杂志，2016，15（11）：849-851，871.

相似文献/References:

[1]郜素云,薛训杰,齐文清,等.肝素佐治重症肺炎(附20例报告)[J].新乡医学院学报,1993,10(04):287.
[2]王红梅,黄丽蓉.重症肺炎患者细胞免疫功能研究[J].新乡医学院学报,2011,28(06):000.
[3]臧　宁,潘海祥,李荣新,等.降钙素原和 Ｃ反应蛋白联合检测在重症肺炎患儿病情和预后评估中的价值[J].新乡医学院学报,2015,32(09):849.
[4]沙正凯,钱　江,张祥杰,等.抗感染联合纤维支气管镜吸痰治疗对重症肺炎患者症状缓解及炎性反应的影响[J].新乡医学院学报,2016,33(12):1091.[doi:10.7683/xxyxyxb.2016.12.020]
　SHA Zheng-kai,QIAN Jiang,ZHANG Xiang-jie,et al.Effect of anti infection combined with fiexible bronchofiberscope aspiration of sputum therapy on symptoms and inflammatory response in patients with severe pulmonary infection[J].Journal of Xinxiang Medical University,2016,33(12):1091.[doi:10.7683/xxyxyxb.2016.12.020]
[5]吴述光,侯小丽,马胜喜.重症肺炎并发脓毒症患者血清高迁移率族蛋白B1检测的临床意义[J].新乡医学院学报,2018,35(2):143.[doi:10.7683/xxyxyxb.2018.02.016]
　WU Shu-guang,HOU Xiao-li,MA Sheng-xi.Clinical significance of high mobility group protein B1 in patients with severe pneumonia complicated with sepsis[J].Journal of Xinxiang Medical University,2018,35(12):143.[doi:10.7683/xxyxyxb.2018.02.016]
[6]刘雪娇,谭晓纯,何　宁.老年重症肺炎患者病原菌分布及支气管镜肺泡灌洗术的治疗效果与安全性[J].新乡医学院学报,2022,39(9):838.[doi:10.7683/xxyxyxb.2022.09.008]
　LIU Xuejiao,TAN Xiaochun,HE Ning.Distribution of pathogenic bacteria in elderly patients with severe pneumonia and the therapeutic effect and safety of bronchoscopy alveolar lavage[J].Journal of Xinxiang Medical University,2022,39(12):838.[doi:10.7683/xxyxyxb.2022.09.008]
[7]曲春雨,卢灵灵,王素魏,等.血清白细胞介素-10和中性粒细胞明胶酶相关脂质运载蛋白水平对纤维支气管镜吸痰灌洗治疗重症肺炎患者预后的预测价值[J].新乡医学院学报,2022,39(10):978.[doi:10.7683/xxyxyxb.2022.10.015]
　QU Chunyu,LU Lingling,WANG Suwei,et al.Predictive value of serum interleukin-10 and neutrophil gelatinase associated lipocalin levels on the prognosis of patients with severe pneumonia treated with sputum aspiration and lavage by fiberoptic bronchoscopy[J].Journal of Xinxiang Medical University,2022,39(12):978.[doi:10.7683/xxyxyxb.2022.10.015]
[8]马群,李卫阳,许蒙.老年重症肺炎并呼吸衰竭患者血清可溶性CD40配体和正五聚体蛋白-3水平变化及临床意义[J].新乡医学院学报,2023,40(7):659.[doi:10.7683/xxyxyxb.2023.07.011]
　MA Qun,LI Weiyang,XU Meng.Changes and clinical significance of serum soluble CD40 ligand and pentraxin-3 levels in elderly patients with severe pneumonia and respiratory failure[J].Journal of Xinxiang Medical University,2023,40(12):659.[doi:10.7683/xxyxyxb.2023.07.011]
[9]苗芝育,张磊,李晓燕,等.乳酸/白蛋白比值、白细胞介素-6、CD4T淋巴细胞计数对重症肺炎并脓毒症患者短期预后的预测价值[J].新乡医学院学报,2024,(3):232.[doi:10.7683/xxyxyxb.2024.03.007]
　MIAO Zhiyu,ZHANG Lei,LI Xiaoyan,et al.Predictive value of lactate/albumin ratio,interleukin-6 and CD4 T lymphocyte count in the short-term prognosis of severe pneumonia and sepsis[J].Journal of Xinxiang Medical University,2024,(12):232.[doi:10.7683/xxyxyxb.2024.03.007]

更新日期/Last Update: 2017-12-05